Device Trial Radar · NCT02100683
Nit-Occlud PDA Post-Approval Study
Last checked: Nov 20, 2026Latest source record: Oct 4, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
184
Actual
Start
Aug 2014
Primary completion
Nov 20, 2019
Study completion Aug 10, 2022
Sponsor
- Lead sponsor
- PFM Medical, IncNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Bright Research Partners
- First posted
- Apr 1, 2014
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 6 months, up to 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The Nit-Occlud PDA Post-Approval Study is designed to continue to evaluate the safety and effectiveness of the device in the post-approval phase.
Conditions
- Patent Ductus Arteriosus (PDA)
Interventions
PDA CoilDevice
The Nit-Occlud PDA is a permanently implanted prosthesis indicated for percutaneous, transcatheter closure of small to moderate size patent ductus arteriosus with a minimum angiographic diameter \< 4 mm.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of Serious Device and/or Procedure Related Adverse Events as a Measure of SafetyTime frame: 24 months (2 year)
1 more outcomes with a free account
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Loma Linda University Medical Center
Loma Linda, California
10 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.